Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer. - Spring LM; Han H; Liu MC; Hamilton E; Irie H; Santa-Maria CA; Reeves J; Pan P; Shan M; Tang Y; Graham JR; Hazard S; et al. (Nature cancer, 2022)